3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 61.30
+0.10 (0.16%)
Apr 2, 2025, 2:56 PM CST
3D Global Biotech Revenue
3D Global Biotech had revenue of 43.67M TWD in the half year ending June 30, 2024, with 585.69% growth. This brings the company's revenue in the last twelve months to 55.15M, up 235.81% year-over-year. In the year 2023, 3D Global Biotech had annual revenue of 20.63M with 51.24% growth.
Revenue (ttm)
55.15M
Revenue Growth
+235.81%
P/S Ratio
66.67
Revenue / Employee
1.67M
Employees
33
Market Cap
4.77B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Center Laboratories | 1.62B |